Vedana Therapeutics: Series ADevelops next-generation therapies for migraine preventionOct 4, 2026RoundOSVedana TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesHealthtechNorth AmericaSeries A